Washington
Washington has comprehensive shield laws (PDF, opens in a new tab) to help protect reproductive and gender-affirming health care provided to patients regardless of their location, which includes telehealth care.
Washington should further strengthen its protections for providers, helpers, and patients by focusing on these policy priorities:
Protect Freedom of Movement: Shield State Reciprocity
Generally, shield laws only protect providers and helpers when they are physically present in the enacting shield state. Providers and helpers need to travel between or relocate to other states for personal and professional reasons without fear that they will be arrested or extradited for engaging in legally protected health care activity in their home state. Through legislation or executive order, states can protect out-of-state providers, patients, and helpers from arrest and extradition so long as they comply with their home-state laws. Designed to enable more freedom of movement, these reciprocity protections also encourage more providers and helpers to meet the access needs of abortion and gender-affirming care seekers. Washington should make this policy a priority in 2027.
Prevent Disclosure of Patients' Medical Information
Research shows that criminal cases brought against people for self-managed abortions (PDF, opens in a new tab) and other pregnancy outcomes (PDF, opens in a new tab) are commonly brought to the attention of law enforcement by health care providers. Although federal law under HIPAA offers some privacy protection for patients’ medical information, HIPAA contains exceptions that some providers have interpreted as permitting them to disclose sensitive patient health information to law enforcement. To counter this, some shield states have enacted more comprehensive privacy protections against health care providers and related entities disclosing a patient’s health information where it may be used to investigate or penalize lawful abortion or gender-affirming care.
Several shield states have also enacted specific protections responding to our interoperable electronic health record system, where medical records may be automatically shared across state lines through health information exchanges (HIEs). HIEs may automatically transfer data from states where abortion and gender-affirming care is lawful to states where it is banned and heavily surveilled. Recognizing this risk, some shield states have enacted laws requiring heightened security within electronic health records for information related to reproductive and gender-affirming care and prohibiting that information from being shared across state lines through HIEs. Washington should make these privacy policies protecting patients’ medical information a priority in 2027.
Protect Against State Misbranding Actions
Despite decades of scientific evidence conclusively demonstrating the safety and effectiveness of mifepristone and other drugs commonly used for medication abortion, the anti-abortion movement has aggressively targeted (opens in a new tab) these medications, including by demanding FDA revoke approval of mifepristone, which was granted more than 25 years ago. Anti-abortion extremists have also demanded that unnecessary and burdensome restrictions be placed on mifepristone, including requiring it to be dispensed in person. Some shield law states have enacted (opens in a new tab) laws designed to protect against claims of misbranding under state law in the event FDA takes action affecting the approval or regulation of mifepristone or other safe and effective drugs used for medication abortion. Washington should make this policy a priority in 2027.